Trending...
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
- New Angles US Group Founder Alexander Harrington Receives Top U.S. Corporate Training Honor and Leads Asia-Pacific Engagements in Taiwan
WAUKESHA, Wis., Aug. 11, 2020 /PRNewswire/ -- Surfacide, a leading UV-C decontamination technology company, announces it has been awarded a contract with Vizient, the largest member-driven healthcare performance improvement company in the country, for Surfacide's innovative multiple emitter UV-C solution. The contract went into July 1.
Vizient serves more than half of the healthcare organizations across the United States – from large integrated delivery networks and academic medical centers to community hospitals, pediatric facilities and non-acute care providers. The contract will allow Vizient members greater access to a solution that has become an integral part to protecting both patients and staff during uncertain times.
While the agreement shows Surfacide's broader commitment to provide Vizient members with evidence-based and cutting-edge solutions at contracted pricing, the launch of the agreement is very timely in the wake of COVID-19. The Surfacide system, which demonstrated efficacy against the MERS Coronavirus in data published from the University of Iowa, is being deployed in facilities across the country as organizations implement solutions in the battle against COVID-19. While the implementation of Surfacide has been in response to the pandemic, many have noted this will be a long-term solution as the mindset around infection prevention has forever changed. The Surfacide system provides an automated UV-C decontamination technology that significantly reduces bacteria, spores and viruses and is effective against a variety of advanced viral infectious diseases. Helios incorporates multiple automated UV-C emitters that work together to provide decontamination of the room in minutes to provide an extra layer of protection.
More on Wisconsin Eagle
"Surfacide is proud of this contract with Vizient and proud to answer the urgent call from countless healthcare facilities that need a solution they can trust to deliver protection for healthcare workers and patients," says Gunner Lyslo, Founder and CEO of Surfacide. "Over the course of the last few months, we've seen UV-C technology emerge as a key tactic in combating coronavirus and other infections. We are confident that Surfacide's agreement with Vizient will allow more healthcare centers to have access to the Surfacide UV-C solution and slow the spread of COVID-19."
About Surfacide LLC
Surfacide LLC and Surfacide Manufacturing Inc., are located in Waukesha, WI and produce multiple emitter UV-C systems.
Surfacide is the only triple emitter UV-C system, providing the most efficient and flexible solution in the fight against viruses and other hospital-acquired infections. Over 400 hospitals nationally and internationally are using Surfacide technology to provide an extra layer of protection for patients and healthcare workers. Surfacide's evidence-based UV-C solution addresses shadows and provides greater coverage for quicker turnaround time and better care. Patients and healthcare workers around the world choose Surfacide as a trusted partner in infection prevention.
More on Wisconsin Eagle
Our mission is to provide patients and healthcare workers with a safe environment and continuous support in infection prevention. We respect and admire the dedication from healthcare professionals and in turn, deliver advanced technology that your team needs to provide the best care possible. Learn more about Surfacide by visiting https://surfacide.com or calling (844)-390-3538.
SOURCE Surfacide
Related Links
http://www.surfacide.com/
Vizient serves more than half of the healthcare organizations across the United States – from large integrated delivery networks and academic medical centers to community hospitals, pediatric facilities and non-acute care providers. The contract will allow Vizient members greater access to a solution that has become an integral part to protecting both patients and staff during uncertain times.
While the agreement shows Surfacide's broader commitment to provide Vizient members with evidence-based and cutting-edge solutions at contracted pricing, the launch of the agreement is very timely in the wake of COVID-19. The Surfacide system, which demonstrated efficacy against the MERS Coronavirus in data published from the University of Iowa, is being deployed in facilities across the country as organizations implement solutions in the battle against COVID-19. While the implementation of Surfacide has been in response to the pandemic, many have noted this will be a long-term solution as the mindset around infection prevention has forever changed. The Surfacide system provides an automated UV-C decontamination technology that significantly reduces bacteria, spores and viruses and is effective against a variety of advanced viral infectious diseases. Helios incorporates multiple automated UV-C emitters that work together to provide decontamination of the room in minutes to provide an extra layer of protection.
More on Wisconsin Eagle
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
- Tom Brady's Cloned Dog Sparks Ethical Debate: Biologist Ben Greulich Joins Marcus Hart
- TAP Announces Acting Classes for Young and Old
- Women's Everyday Safety Is Changing - The Blue Luna Shows How
- Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
"Surfacide is proud of this contract with Vizient and proud to answer the urgent call from countless healthcare facilities that need a solution they can trust to deliver protection for healthcare workers and patients," says Gunner Lyslo, Founder and CEO of Surfacide. "Over the course of the last few months, we've seen UV-C technology emerge as a key tactic in combating coronavirus and other infections. We are confident that Surfacide's agreement with Vizient will allow more healthcare centers to have access to the Surfacide UV-C solution and slow the spread of COVID-19."
About Surfacide LLC
Surfacide LLC and Surfacide Manufacturing Inc., are located in Waukesha, WI and produce multiple emitter UV-C systems.
Surfacide is the only triple emitter UV-C system, providing the most efficient and flexible solution in the fight against viruses and other hospital-acquired infections. Over 400 hospitals nationally and internationally are using Surfacide technology to provide an extra layer of protection for patients and healthcare workers. Surfacide's evidence-based UV-C solution addresses shadows and provides greater coverage for quicker turnaround time and better care. Patients and healthcare workers around the world choose Surfacide as a trusted partner in infection prevention.
More on Wisconsin Eagle
- 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
- The End of "Influencer" Gambling: Bonusetu Analyzes Finland's Strict New Casino Marketing Laws
- AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue
- TRIO Heating, Air & Plumbing Now Ranks #1 in San Jose
- Milwaukee Job Corps Center Hosts Alumni Day, Calls Alumni to Action on Open Enrollment Campaign
Our mission is to provide patients and healthcare workers with a safe environment and continuous support in infection prevention. We respect and admire the dedication from healthcare professionals and in turn, deliver advanced technology that your team needs to provide the best care possible. Learn more about Surfacide by visiting https://surfacide.com or calling (844)-390-3538.
SOURCE Surfacide
Related Links
http://www.surfacide.com/
0 Comments
Latest on Wisconsin Eagle
- Artificial Intelligence Leader Releases Children's Book on Veterans Day
- Felicia Allen Hits #1 Posthumously with "Christmas Means Worship"
- CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
- Tokenized Real-World Assets: Iguabit Brings Institutional Investment Opportunities to Brazil
- MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi
- From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
- New Angles US Group Founder Alexander Harrington Receives Top U.S. Corporate Training Honor and Leads Asia-Pacific Engagements in Taiwan
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- UK Financial Ltd Sets Official 30-Day Conversion Deadline for Three Exchange Listed Tokens Ahead of Regulated Upgrade
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
- Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case
- Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
- Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
- IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
- Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
- EnergyStrat Launches Global LNG Risk Outlook 2025–2030
- Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Holiday Decorations Most Likely to Cause Injuries
- UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
- CCHR Florida Joins Global Call to Ban Electroshock Treatment, Citing New Evidence of Widespread Patient Harm